Data & Intelligence

China Data Insight (Year-End 2019)

Health care emerged as a top sector for investment in China in 2019 on the eve of the coronavirus crisis

Health care emerged as a top sector for investment in 2019, as capital invested grew 22% from 2018 to reach USD8.9 billion. In particular, investors flocked to advanced pharma­ceutical and biotechnology companies. Notable deals included PAG’s USD532 million buyout of Hisun BioRay, as well as Boyu Capital’s investment of USD249 million in Hansoh Pharmaceuticals. Companies providing contract research organization (CRO) services to the pharmaceutical industry also drew strong investor interest, illustrated by Akeso Biopharma’s USD150m Series D round led by Loyal Valley Capital. The novel coronavirus outbreak had just surfaced by the end of 2019, and the full impact on China’s domestic economy and the global economy remains unknown. The crisis may spur investors in China to further refine health care strategies and deploy capital creatively across all sectors.


EMPEA represents the leading global investors in EM. I look forward to working alongside to drive much-needed capital for financing entrepreneurs and businesses worldwide.

Renuka Ramnath | Founder, Managing Director & Chief Executive Officer, Multiples Alternate Asset Management Private Limited

EMPEA plays an important and energetic role across the markets it represents, driving outreach and research initiatives, and promoting the role of private capital.

Brian Lim | Partner and Head of Asia and Emerging Markets, Pantheon Ventures

The developed markets have no equivalent to the role EMPEA is playing as a convener and source of trusted information in the emerging markets.

David Rubenstein | Co-Founder and Co-Executive Chairman, The Carlyle Group

I’m honored to join fellow industry pioneers in the leadership of an unparalleled network, filled with first movers, shaping the future of industries and communities.

Dr. Andrew Kuper | Founder and CEO, LeapFrog Investments

EMPEA's market and industry intelligence opens doors to new sources of capital.  I look forward to the future success of EMPEA and its members.

Torbjorn Caesar | Senior Partner, Actis

While there are certainly challenges for the industry, the opportunities abound in our target markets and globally, making a global association like EMPEA more relevant than ever.

Drew Guff | Managing Director & Founding Partner, Siguler Guff & Company